<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10348834</article-id>
    <article-id pub-id-type="pmid">37402621</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btad423</article-id>
    <article-id pub-id-type="publisher-id">btad423</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Note</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Sequence Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MEDIPIPE: an automated and comprehensive pipeline for cfMeDIP-seq data quality control and analysis</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5719-1272</contrib-id>
        <name>
          <surname>Zeng</surname>
          <given-names>Yong</given-names>
        </name>
        <aff><institution>Princess Margaret Cancer Centre, University Health Network</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
        <xref rid="btad423-cor1" ref-type="corresp"/>
        <!--yzeng@uhnresearch.ca-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ye</surname>
          <given-names>Wenbin</given-names>
        </name>
        <aff><institution>Princess Margaret Cancer Centre, University Health Network</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stutheit-Zhao</surname>
          <given-names>Eric Y</given-names>
        </name>
        <aff><institution>Princess Margaret Cancer Centre, University Health Network</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Han</surname>
          <given-names>Ming</given-names>
        </name>
        <aff><institution>Princess Margaret Cancer Centre, University Health Network</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bratman</surname>
          <given-names>Scott V</given-names>
        </name>
        <aff><institution>Princess Margaret Cancer Centre, University Health Network</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
        <aff><institution>Department of Medical Biophysics, University of Toronto</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8073-5888</contrib-id>
        <name>
          <surname>Pugh</surname>
          <given-names>Trevor J</given-names>
        </name>
        <aff><institution>Princess Margaret Cancer Centre, University Health Network</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
        <aff><institution>Department of Medical Biophysics, University of Toronto</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
        <aff><institution>Ontario Institute for Cancer Research</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
        <xref rid="btad423-cor1" ref-type="corresp"/>
        <!--trevor.pugh@utoronto.ca-->
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>He</surname>
          <given-names>Housheng Hansen</given-names>
        </name>
        <aff><institution>Princess Margaret Cancer Centre, University Health Network</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
        <aff><institution>Department of Medical Biophysics, University of Toronto</institution>, Toronto, Ontario, <country country="CA">Canada</country></aff>
        <xref rid="btad423-cor1" ref-type="corresp"/>
        <!--hansenhe@uhnresearch.ca-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Robinson</surname>
          <given-names>Peter</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btad423-cor1">Corresponding authors. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. E-mails: <email>yzeng@uhnresearch.ca</email> (Y.Z.), <email>trevor.pugh@utoronto.ca</email> (T.J.P.) and <email>hansenhe@uhnresearch.ca</email> (H.H.H.)</corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-07-04">
      <day>04</day>
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>04</day>
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <volume>39</volume>
    <issue>7</issue>
    <elocation-id>btad423</elocation-id>
    <history>
      <date date-type="received">
        <day>04</day>
        <month>4</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>06</day>
        <month>6</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>26</day>
        <month>6</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>03</day>
        <month>7</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>14</day>
        <month>7</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2023. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btad423.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Cell-free methylated DNA immunoprecipitation and high-throughput sequencing (cfMeDIP-seq) has emerged as a promising liquid biopsy technology to detect cancers and monitor treatments. While several bioinformatics tools for DNA methylation analysis have been adapted for cfMeDIP-seq data, an end-to-end pipeline and quality control framework specifically for this data type is still lacking. Here, we present the MEDIPIPE, which provides a one-stop solution for cfMeDIP-seq data quality control, methylation quantification, and sample aggregation. The major advantages of MEDIPIPE are: (i) ease of implementation and reproducibility with Snakemake containerized execution environments that will be automatically deployed via Conda; (ii) flexibility to handle different experimental settings with a single configuration file; and (iii) computationally efficiency for large-scale cfMeDIP-seq profiling data analysis and aggregation.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>This pipeline is an open-source software under the MIT license and it is freely available at <ext-link xlink:href="https://github.com/pughlab/MEDIPIPE" ext-link-type="uri">https://github.com/pughlab/MEDIPIPE</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Cancer Genetics and Epigenetics</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Cancer Research Institute Irvington Postdoctoral Fellowship</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>The cell-free DNA (cfDNA) in blood has been a promising analyte for cancer prognosis and treatment monitoring (<xref rid="btad423-B4" ref-type="bibr">Corcoran and Chabner 2018</xref>). Genomic technologies have been tailored to identify cfDNA genomic and epigenomic signatures associated with cancer phenotypes. Among them, the epigenomic profiling through cell-free methylated DNA (5-Methylcytosine) immunoprecipitation and high-throughput sequencing (cfMeDIP-seq) (<xref rid="btad423-B19" ref-type="bibr">Shen <italic toggle="yes">et al.</italic> 2018</xref>) has proven capable of ultrasensitive tumor detection and classification, particularly in the setting of early-stage cancer or residual disease after treatments (<xref rid="btad423-B19" ref-type="bibr">Shen <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad423-B16" ref-type="bibr">Nassiri <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad423-B17" ref-type="bibr">Nuzzo <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad423-B2" ref-type="bibr">Burgener <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="btad423-B13" ref-type="bibr">Liu <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="btad423-B3" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="btad423-B23" ref-type="bibr">Wong <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="btad423-B24" ref-type="bibr">2023</xref>). Refined cfMeDIP-seq protocols incorporating spike-in controls and/or unique molecular identifiers (UMIs) also offer improved capabilities for batch effect correction and sequence error-suppression (<xref rid="btad423-B18" ref-type="bibr">Shen <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="btad423-B2" ref-type="bibr">Burgener <italic toggle="yes">et al.</italic> 2021</xref>). The existing MeDIP-seq data analysis tools and pipelines, like MEDIPS (<xref rid="btad423-B8" ref-type="bibr">Lienhard <italic toggle="yes">et al.</italic> 2014</xref>), MeQA (<xref rid="btad423-B7" ref-type="bibr">Huang <italic toggle="yes">et al.</italic> 2012</xref>), and meDUSA (<xref rid="btad423-B21" ref-type="bibr">Wilson <italic toggle="yes">et al.</italic> 2012</xref>), have been adapted for cfMeDIP-seq data analysis by incorporating extra procedures, such as sequencing bias suppression, fragmental features evaluation, and spike-in controls processing. However, these studies have utilized different modified workflows, and a comprehensive, unified pipeline specifically designed for large-scale cfMeDIP-seq data processing and analysis is currently lacking. Consequently, these also challenge downstream tertiary analysis combining and comparing data across studies.</p>
    <p>Here, we present an open-source pipeline, MEDIPIPE, to provide an automated and comprehensive solution for cfMeDIP-seq data quality control (QC), methylation quantification, and data aggregation. This pipeline was developed using Snakemake (v6.12.3) (<xref rid="btad423-B15" ref-type="bibr">MÃ¶lder <italic toggle="yes">et al.</italic> 2021</xref>), ensuring all dependencies are automatically installed and execution is seamless and reproducible. Through a single input configuration file, this pipeline supports various experimental settings, such as single-end or paired-end sequencing reads, and whether spike-in controls and/or UMIs were employed. Moreover, it can efficiently deal with large-scale cfMeDIP-seq profiling data on high performance computing clusters, because all independent steps for individual samples are run in parallel.</p>
  </sec>
  <sec>
    <title>2 Pipeline description</title>
    <p>MEDIPIPE consists of four modules: (i) read trimming and QC; (ii) processed read alignment and QC; (iii) DNA methylation quantification; and (iv) data aggregation and filtering (<xref rid="btad423-F1" ref-type="fig">Fig.Â 1</xref>). It starts with parsing the input configuration file with user customized experimental settings, and subsequently conducting corresponding branches in each module to get comprehensive QC and quantification outcomes (<xref rid="btad423-F1" ref-type="fig">Fig.Â 1</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S1âS3</xref>).</p>
    <fig position="float" id="btad423-F1">
      <label>Figure 1.</label>
      <caption>
        <p>Flowchart of the MEDIPIPE pipeline. UMI, unique molecular identifiers; QC, quality control; w/wo, with or without; stats, statistics; Quant(s), quantification(s).</p>
      </caption>
      <graphic xlink:href="btad423f1" position="float"/>
    </fig>
    <sec>
      <title>2.1 Input of pipeline</title>
      <p>A single input configuration file in YAML format is required for successfully running MEDIPIPE, which specifies the paths to the working environment, genome references, sample information, as well as parameters for different experimental settings (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). Instructions and a detailed template are also included in the GitHub repository. Notably, the sequencing reads can be either single-end or paired-end gzip-compressed FASTQ files, and multiple FASTQ files (e.g. multiple sequencing runs) for the same biological sample can be merged by specifying them in the sample sequencing data table (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). We also provide shell scripts for automatically downloading ENCODE pre-built genome references (e.g. BWA index and annotated regions) (<xref rid="btad423-B14" ref-type="bibr">Luo <italic toggle="yes">et al.</italic> 2020</xref>), or building customized genome references (e.g. when spike-in sequences need to be added to the primary genome reference).</p>
    </sec>
    <sec>
      <title>2.2 Read trimming and QC</title>
      <p>First, the adapter sequence and low low-quality bases of raw reads are removed by Trim Galore (v0.6.7) (<ext-link xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/" ext-link-type="uri">https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/</ext-link>). If UMI barcodes were added into the library for sequence error suppression, UMI-tools (v1.0.1) (<xref rid="btad423-B20" ref-type="bibr">Smith <italic toggle="yes">et al.</italic> 2017</xref>) will be executed prior to Trim Galore to extract barcodes and filter out reads which do not contain expected barcode sequence. Specifically, the regex method allowing for variable barcode length is applied. Lastly, FastQC (v0.11.9) (<ext-link xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/" ext-link-type="uri">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>) is applied to check the qualities of both raw and processed reads. All of these steps can operate on single-end or paired-end sequencing data (<xref rid="btad423-F1" ref-type="fig">Fig.Â 1</xref>).</p>
    </sec>
    <sec>
      <title>2.3 Processed read alignment and QC</title>
      <p>Next, the processed reads are mapped back to corresponding genome(s) via BWA-MEM (v0.7.17) (<xref rid="btad423-B10" ref-type="bibr">Li 2013</xref>). For experiments that utilize spike-in controls, we recommend appending spike-in sequences to the primary genome for alignment simultaneously. Aligned spike-in reads can be extracted for separate quantity assessment and quantification (<xref rid="btad423-B22" ref-type="bibr">Wilson <italic toggle="yes">et al.</italic> 2022</xref>), which is specified in the configuration file (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). Then, SAMtools (v1.17) (<xref rid="btad423-B12" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2009</xref>) is applied to filter out unmapped reads and secondary alignments, as well as improperly paired mates for paired-end reads. Duplicated reads will be removed either by SAMtools markdup (<xref rid="btad423-B12" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2009</xref>) or UMI-tools dedup (<xref rid="btad423-B20" ref-type="bibr">Smith <italic toggle="yes">et al.</italic> 2017</xref>), depending on whether UMI barcodes were added or not (<xref rid="btad423-F1" ref-type="fig">Fig.Â 1</xref>). Specific to paired-end reads, the fragment size will be estimated by CollectInsertSizeMetrics from Picard tool kit (v2.26.6) (<ext-link xlink:href="http://broadinstitute.github.io/picard/" ext-link-type="uri">http://broadinstitute.github.io/picard/</ext-link>). Fragmentation size ratios of short to long fragments in consecutive 1 and 5âMb windows are computed as well (<xref rid="btad423-B5" ref-type="bibr">Cristiano <italic toggle="yes">et al.</italic> 2019</xref>). Lastly, QC metrics derived from the aligned reads, including BAM files statistics via SAMtools (<xref rid="btad423-B12" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2009</xref>) and cfMeDIP-seq saturation, coverage, and enrichment scores via MEDIPS (<xref rid="btad423-B8" ref-type="bibr">Lienhard <italic toggle="yes">et al.</italic> 2014</xref>), are collected.</p>
    </sec>
    <sec>
      <title>2.4 DNA methylation quantification</title>
      <p>The cfMeDIP-seq offers higher coverage and sensitivity of methylated CpG dinucleotides throughout the genome with lower input requirements compared to bisulfite-based methods. However, the absolute methylation levels can only be estimated using a computational model for this enrichment based profiling method. MEDIPIPE applies three successively developed methods for relative and absolute methylation estimation using different models to eliminate CpG density bias: MEDIPS (v1.46.0) (linear regression) (<xref rid="btad423-B8" ref-type="bibr">Lienhard <italic toggle="yes">et al.</italic> 2014</xref>), QSEA (v1.20.0) (sigmoidal model with empirical knowledge) (<xref rid="btad423-B9" ref-type="bibr">Lienhard <italic toggle="yes">et al.</italic> 2017</xref>) and MEDStrand (v0.0.0.9000) (stranded sigmoid model) (<xref rid="btad423-B25" ref-type="bibr">Xu <italic toggle="yes">et al.</italic> 2018</xref>). These options allow users to choose normalization strategy appropriate for their application and enable a comprehensive comparison among different algorithms. If there are spike-in controls, MEDIPS (<xref rid="btad423-B8" ref-type="bibr">Lienhard <italic toggle="yes">et al.</italic> 2014</xref>) is used to separately quantify the methylation levels for these controls as well.</p>
    </sec>
    <sec>
      <title>2.5 Data aggregation and filtering</title>
      <p>Since many cfMeDIP-seq profiling projects generate data for a large number of samples in multiple groups or batches, the final module of MEDIPIPE can aggregate QC metrics and methylation matrices across all samples for each such project. Namely, first, all QC reports generated by FASTQC, SAMtools, Picard, and MEDIPS are aggregated by MultiQC (v1.0.dev0) (<xref rid="btad423-B6" ref-type="bibr">Ewels <italic toggle="yes">et al.</italic> 2016</xref>) and an embedded script. On top of that, a summarized QC report in HTML format with selected QC metrics is generated, allowing users to interactively examine sample QC metrics across different groups or batches (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). Meanwhile, different methylation quantifications are aggregated into corresponding TAB-delimited bin-sample TXT files, as well as uniformly filtered out sex chromosomes, mitochondrial chromosome, and ENCODE blacklist regions (<xref rid="btad423-B1" ref-type="bibr">Amemiya <italic toggle="yes">et al.</italic> 2019</xref>). Both original and filtered aggregated quantification files are indexed by Tabix (v1.17) (<xref rid="btad423-B11" ref-type="bibr">Li 2011</xref>), enabling rapid retrieval of data for genomic regions of interest for downstream analysis.</p>
    </sec>
    <sec>
      <title>2.6 Outputs of pipeline</title>
      <p>All outputs of MEDIPIPE are organized in corresponding folders. Specifically, the main output files per sample can be grouped into four categories: QC reports, aligned BAM files, fragmentomic features (for paired-end reads only), and methylation quantifications (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>). Moreover, the aggregated outputs include multiQC reports, aggregated QC reports, as well as the aggregated methylation quantification before and after filtering (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>).</p>
    </sec>
  </sec>
  <sec>
    <title>3 Implementation</title>
    <p>MEDIPIPE was developed with Snakemake following a modular design in accordance with best practice coding standards so that other specialized tools can be added in the future. Detailed instructions on how to install and run this pipeline are presented in <ext-link xlink:href="https://github.com/pughlab/MEDIPIPE" ext-link-type="uri">https://github.com/pughlab/MEDIPIPE</ext-link>. This pipeline is highly flexible thanks to the input configuration file, which provides options and parameters for different experimental settings and analyses. The pipeline can be run locally or submitted to a high performance computing system for efficient scheduling within a multiprocessor environment. As a demonstration dataset of aggregated methylation quantifications and QC reports, we have applied MEDIPIPE to the published cfMeDIP-seq dataset (<xref rid="btad423-B16" ref-type="bibr">Nassiri <italic toggle="yes">et al.</italic> 2020</xref>), which consists of 163 samples from 6 brain cancer subtypes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). Lastly, although this pipeline was originally developed for cfMeDIP-seq data, we expect there is application for analysis of conventional methylated DNA immunoprecipitation followed by sequencing (MeDIP-seq) data.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btad423_Supplementary_Data</label>
      <media xlink:href="btad423_supplementary_data.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We like to thank Sasha Main, Emma Bell, Nicholas Cheng, Althaf Singhawansa, and Justin Burgener for acting as beta-testers and providing critical feedback. We would also like to thank members of the cell-free Multiomics Data Coordination Centre (cfMOS-DCC) for supporting this project and facilitating access to cfMeDIP-seq data.</p>
  </ack>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>S.V.B.: stock ownership in Adela; leadership position in Adela; patents licensed to Roche, Adela; and royalties from Roche. T.J.P. reports personal fees from AstraZeneca, Canadian Pension Plan Investment Board, Chrysalis Biomedical Advisors, Illumina, Merck, PACT Pharma, and SAGA Diagnostics, and grants from Roche/Genentech outside the submitted work.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by The Cancer Genetics and Epigenetics (TCGE) program at Princess Margaret Cancer Centre. E.Y.S.-Z. was funded by a Cancer Research Institute Irvington Postdoctoral Fellowship. T.J.P. holds the Canada Research Chair in Translational Genomics and is supported by a Senior Investigator Award from the Ontario Institute for Cancer Research and the Gattuso-Slaight Personalized Cancer Medicine Fund. H.H.H. holds Joey and Toby Tanenbaum Brazilian Ball Chair in Prostate Cancer.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btad423-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amemiya</surname><given-names>HM</given-names></string-name>, <string-name><surname>Kundaje</surname><given-names>A</given-names></string-name>, <string-name><surname>Boyle</surname><given-names>AP</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>The ENCODE blacklist: identification of problematic regions of the genome</article-title>. <source>Sci Rep</source> Â <year>2019</year>;<volume>9</volume>:<fpage>9354</fpage>.<pub-id pub-id-type="pmid">31249361</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burgener</surname><given-names>JM</given-names></string-name>, <string-name><surname>Zou</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Z</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Tumor-naÃ¯ve multimodal profiling of circulating tumor DNA in head and neck squamous cell carcinoma</article-title>. <source>Clin Cancer Res</source> Â <year>2021</year>;<volume>27</volume>:<fpage>4230</fpage>â<lpage>44</lpage>.<pub-id pub-id-type="pmid">34158359</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>S</given-names></string-name>, <string-name><surname>Petricca</surname><given-names>J</given-names></string-name>, <string-name><surname>Ye</surname><given-names>W</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors</article-title>. <source>Nat Commun</source> Â <year>2022</year>;<volume>13</volume>:<fpage>6467</fpage>.<pub-id pub-id-type="pmid">36309516</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corcoran</surname><given-names>RB</given-names></string-name>, <string-name><surname>Chabner</surname><given-names>BA.</given-names></string-name></person-group> Â <article-title>Application of cell-free DNA analysis to cancer treatment</article-title>. <source>N Engl J Med</source> Â <year>2018</year>;<volume>379</volume>:<fpage>1754</fpage>â<lpage>65</lpage>.<pub-id pub-id-type="pmid">30380390</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cristiano</surname><given-names>S</given-names></string-name>, <string-name><surname>Leal</surname><given-names>A</given-names></string-name>, <string-name><surname>Phallen</surname><given-names>J</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Genome-wide cell-free DNA fragmentation in patients with cancer</article-title>. <source>Nature</source> Â <year>2019</year>;<volume>570</volume>:<fpage>385</fpage>â<lpage>9</lpage>.<pub-id pub-id-type="pmid">31142840</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ewels</surname><given-names>P</given-names></string-name>, <string-name><surname>Magnusson</surname><given-names>M</given-names></string-name>, <string-name><surname>Lundin</surname><given-names>S</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>MultiQC: summarize analysis results for multiple tools and samples in a single report</article-title>. <source>Bioinformatics</source> Â <year>2016</year>;<volume>32</volume>:<fpage>3047</fpage>â<lpage>8</lpage>.<pub-id pub-id-type="pmid">27312411</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>J</given-names></string-name>, <string-name><surname>Renault</surname><given-names>V</given-names></string-name>, <string-name><surname>SengenÃ¨s</surname><given-names>J</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>MeQA: a pipeline for MeDIP-seq data quality assessment and analysis</article-title>. <source>Bioinformatics</source> Â <year>2012</year>;<volume>28</volume>:<fpage>587</fpage>â<lpage>8</lpage>.<pub-id pub-id-type="pmid">22199384</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lienhard</surname><given-names>M</given-names></string-name>, <string-name><surname>Grimm</surname><given-names>C</given-names></string-name>, <string-name><surname>Morkel</surname><given-names>M</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments</article-title>. <source>Bioinformatics</source> Â <year>2014</year>;<volume>30</volume>:<fpage>284</fpage>â<lpage>6</lpage>.<pub-id pub-id-type="pmid">24227674</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lienhard</surname><given-names>M</given-names></string-name>, <string-name><surname>Grasse</surname><given-names>S</given-names></string-name>, <string-name><surname>Rolff</surname><given-names>J</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experiments</article-title>. <source>Nucleic Acids Res</source> Â <year>2017</year>;<volume>45</volume>:<fpage>e44</fpage>.<pub-id pub-id-type="pmid">27913729</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B10">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>H.</given-names></string-name></person-group> Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. <year>2013</year>. <pub-id pub-id-type="doi">10.48550/arXiv.1303.3997</pub-id>.</mixed-citation>
    </ref>
    <ref id="btad423-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>H.</given-names></string-name></person-group> Â <article-title>Tabix: fast retrieval of sequence features from generic TAB-delimited files</article-title>. <source>Bioinformatics</source> Â <year>2011</year>;<volume>27</volume>:<fpage>718</fpage>â<lpage>9</lpage>.<pub-id pub-id-type="pmid">21208982</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>H</given-names></string-name>, <string-name><surname>Handsaker</surname><given-names>B</given-names></string-name>, <string-name><surname>Wysoker</surname><given-names>A</given-names></string-name></person-group> Â <etal>et al</etal>; <collab>1000 Genome Project Data Processing Subgroup</collab>. <article-title>The sequence alignment/map format and SAMtools</article-title>. <source>Bioinformatics</source> Â <year>2009</year>;<volume>25</volume>:<fpage>2078</fpage>â<lpage>9</lpage>.<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>H</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer</article-title>. <source>Mol Cancer</source> Â <year>2021</year>;<volume>20</volume>:<fpage>36</fpage>.<pub-id pub-id-type="pmid">33608029</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luo</surname><given-names>Y</given-names></string-name>, <string-name><surname>Hitz</surname><given-names>BC</given-names></string-name>, <string-name><surname>Gabdank</surname><given-names>I</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>New developments on the encyclopedia of DNA elements (ENCODE) data portal</article-title>. <source>Nucleic Acids Res</source> Â <year>2020</year>;<volume>48</volume>:<fpage>D882</fpage>â<lpage>9</lpage>.<pub-id pub-id-type="pmid">31713622</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MÃ¶lder</surname><given-names>F</given-names></string-name>, <string-name><surname>Jablonski</surname><given-names>KP</given-names></string-name>, <string-name><surname>Letcher</surname><given-names>B</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Sustainable data analysis with Snakemake</article-title>. <source>F1000Res</source> Â <year>2021</year>;<volume>10</volume>:<fpage>33</fpage>.<pub-id pub-id-type="pmid">34035898</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nassiri</surname><given-names>F</given-names></string-name>, <string-name><surname>Chakravarthy</surname><given-names>A</given-names></string-name>, <string-name><surname>Feng</surname><given-names>S</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes</article-title>. <source>Nat Med</source> Â <year>2020</year>;<volume>26</volume>:<fpage>1044</fpage>â<lpage>7</lpage>.<pub-id pub-id-type="pmid">32572265</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nuzzo</surname><given-names>PV</given-names></string-name>, <string-name><surname>Berchuck</surname><given-names>JE</given-names></string-name>, <string-name><surname>Korthauer</surname><given-names>K</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes</article-title>. <source>Nat Med</source> Â <year>2020</year>;<volume>26</volume>:<fpage>1041</fpage>â<lpage>3</lpage>.<pub-id pub-id-type="pmid">32572266</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shen</surname><given-names>SY</given-names></string-name>, <string-name><surname>Burgener</surname><given-names>JM</given-names></string-name>, <string-name><surname>Bratman</surname><given-names>SV</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA</article-title>. <source>Nat Protoc</source> Â <year>2019</year>;<volume>14</volume>:<fpage>2749</fpage>â<lpage>80</lpage>.<pub-id pub-id-type="pmid">31471598</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shen</surname><given-names>SY</given-names></string-name>, <string-name><surname>Singhania</surname><given-names>R</given-names></string-name>, <string-name><surname>Fehringer</surname><given-names>G</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Sensitive tumour detection and classification using plasma cell-free DNA methylomes</article-title>. <source>Nature</source> Â <year>2018</year>;<volume>563</volume>:<fpage>579</fpage>â<lpage>83</lpage>.<pub-id pub-id-type="pmid">30429608</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>T</given-names></string-name>, <string-name><surname>Heger</surname><given-names>A</given-names></string-name>, <string-name><surname>Sudbery</surname><given-names>I</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy</article-title>. <source>Genome Res</source> Â <year>2017</year>;<volume>27</volume>:<fpage>491</fpage>â<lpage>9</lpage>.<pub-id pub-id-type="pmid">28100584</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilson</surname><given-names>GA</given-names></string-name>, <string-name><surname>Dhami</surname><given-names>P</given-names></string-name>, <string-name><surname>Feber</surname><given-names>A</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Resources for methylome analysis suitable for gene knockout studies of potential epigenome modifiers</article-title>. <source>Gigascience</source> Â <year>2012</year>;<volume>1</volume>:<fpage>3</fpage>.<pub-id pub-id-type="pmid">23587164</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilson</surname><given-names>SL</given-names></string-name>, <string-name><surname>Shen</surname><given-names>SY</given-names></string-name>, <string-name><surname>Harmon</surname><given-names>L</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Sensitive and reproducible cell-free methylome quantification with synthetic spike-in controls</article-title>. <source>Cell Rep Methods</source> Â <year>2022</year>;<volume>2</volume>:<fpage>100294</fpage>.<pub-id pub-id-type="pmid">36160046</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B23">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Wong</surname><given-names>D, Luo P, Oldfield L </given-names></string-name></person-group><etal>et al</etal> Integrated analysis of cell-free DNA for the early detection of cancer in people with Li-Fraumeni Syndrome. <italic toggle="yes">medRxiv</italic> Â <year>2022</year>;2022.10.07.22280848, preprint: not peer reviewed. <pub-id pub-id-type="doi">10.1101/2022.10.07.22280848</pub-id>.</mixed-citation>
    </ref>
    <ref id="btad423-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wong</surname><given-names>D</given-names></string-name>, <string-name><surname>Luo</surname><given-names>P</given-names></string-name>, <string-name><surname>Znassi</surname><given-names>N</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>Integrated, longitudinal analysis of cell-free DNA in uveal melanoma</article-title>. <source>Cancer Res Commun</source> Â <year>2023</year>;<volume>3</volume>:<fpage>267</fpage>â<lpage>80</lpage>.<pub-id pub-id-type="pmid">36860651</pub-id></mixed-citation>
    </ref>
    <ref id="btad423-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname><given-names>J</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name><surname>Yin</surname><given-names>P</given-names></string-name></person-group> Â <etal>et al</etal> Â <article-title>MeDEStrand: an improved method to infer genome-wide absolute methylation levels from DNA enrichment data</article-title>. <source>BMC Bioinformatics</source> Â <year>2018</year>;<volume>19</volume>:<fpage>540</fpage>.<pub-id pub-id-type="pmid">30577750</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
